JP2023503797A5 - - Google Patents
Info
- Publication number
- JP2023503797A5 JP2023503797A5 JP2022520680A JP2022520680A JP2023503797A5 JP 2023503797 A5 JP2023503797 A5 JP 2023503797A5 JP 2022520680 A JP2022520680 A JP 2022520680A JP 2022520680 A JP2022520680 A JP 2022520680A JP 2023503797 A5 JP2023503797 A5 JP 2023503797A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- sequence
- nucleic acid
- acid sequence
- mgs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025132078A JP2025166082A (ja) | 2019-10-01 | 2025-08-07 | 分子ガイドシステムペプチド及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908687P | 2019-10-01 | 2019-10-01 | |
| US62/908,687 | 2019-10-01 | ||
| PCT/US2020/044510 WO2021066931A1 (en) | 2019-10-01 | 2020-07-31 | Molecular guide system peptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132078A Division JP2025166082A (ja) | 2019-10-01 | 2025-08-07 | 分子ガイドシステムペプチド及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503797A JP2023503797A (ja) | 2023-02-01 |
| JP2023503797A5 true JP2023503797A5 (https=) | 2023-08-07 |
Family
ID=75337452
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520680A Pending JP2023503797A (ja) | 2019-10-01 | 2020-07-31 | 分子ガイドシステムペプチド及びその使用 |
| JP2025132078A Pending JP2025166082A (ja) | 2019-10-01 | 2025-08-07 | 分子ガイドシステムペプチド及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132078A Pending JP2025166082A (ja) | 2019-10-01 | 2025-08-07 | 分子ガイドシステムペプチド及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220380764A1 (https=) |
| EP (2) | EP4360655A3 (https=) |
| JP (2) | JP2023503797A (https=) |
| CN (1) | CN115243699A (https=) |
| AU (1) | AU2020357455B2 (https=) |
| WO (1) | WO2021066931A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023288301A1 (en) * | 2021-07-15 | 2023-01-19 | Cornell University | Engineered biomolecules for nutrient reprogramming |
| JP7684523B2 (ja) * | 2021-12-21 | 2025-05-27 | エスアールアイ インターナショナル | 中枢神経系への細胞特異的輸送のための二重標的化 |
| WO2025006452A2 (en) * | 2023-06-26 | 2025-01-02 | Sri International | NEU5GC-LEWISa-TARGETING MOLECULES AND USES THEREOF IN CANCER |
| WO2025240414A1 (en) * | 2024-05-14 | 2025-11-20 | Sri International | Cardiomyocyte-specific molecular guidance system peptides and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010526091A (ja) * | 2007-04-30 | 2010-07-29 | インテザイン テクノロジーズ， インコーポレイテッド | 癌の処置のための生物学的な標的基の改変 |
| WO2009089186A2 (en) * | 2008-01-05 | 2009-07-16 | Sloan-Kettering Institute For Cancer Research | Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
| US9382540B2 (en) * | 2014-05-01 | 2016-07-05 | Isis Pharmaceuticals, Inc | Compositions and methods for modulating angiopoietin-like 3 expression |
| EP3652196A4 (en) * | 2017-07-10 | 2021-08-18 | Brown, Kathlynn, C. | MOLECULAR GUIDANCE SYSTEMPEPTIDES AND USES THEREOF |
| JP2020527556A (ja) * | 2017-07-10 | 2020-09-10 | エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ | がん治療用ペプチドサポリン複合体 |
| WO2019017199A1 (ja) * | 2017-07-21 | 2019-01-24 | 株式会社豊田自動織機 | 正極活物質 |
-
2020
- 2020-07-31 AU AU2020357455A patent/AU2020357455B2/en active Active
- 2020-07-31 EP EP24158150.3A patent/EP4360655A3/en active Pending
- 2020-07-31 JP JP2022520680A patent/JP2023503797A/ja active Pending
- 2020-07-31 WO PCT/US2020/044510 patent/WO2021066931A1/en not_active Ceased
- 2020-07-31 US US17/766,109 patent/US20220380764A1/en active Pending
- 2020-07-31 EP EP20871090.5A patent/EP4041272A4/en not_active Withdrawn
- 2020-07-31 CN CN202080069792.1A patent/CN115243699A/zh active Pending
-
2025
- 2025-08-07 JP JP2025132078A patent/JP2025166082A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503797A5 (https=) | ||
| Omidi et al. | Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin-and oligofectamine-induced gene expression changes in human epithelial cells | |
| JP4974890B2 (ja) | ペプチドが結合された、イノシン置換アンチセンスオリゴマー化合物および方法 | |
| CN111989113B (zh) | 用于治疗癌症的包含向导rna和核酸内切酶作活性成分的药物组合物 | |
| Kundu et al. | Synthesis of phosphorodiamidate morpholino oligonucleotides using trityl and fmoc chemistry in an automated oligo synthesizer | |
| KR20220044811A (ko) | Crispr/cas13을 사용하는 표적화된 트랜스-이어맞추기 | |
| EP2632932A2 (en) | Compositions and methods for activating expression by a specific endogenous mirna | |
| JP2018521970A (ja) | ペプチドオリゴヌクレオチドコンジュゲート | |
| JP2022023144A5 (https=) | ||
| JP2025081638A5 (https=) | ||
| JP2024511131A5 (https=) | ||
| JP2023085547A (ja) | ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤 | |
| Staroseletz et al. | ‘Dual’peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNA | |
| Yu et al. | Roles of ANP32 proteins in cell biology and viral replication | |
| US20210332094A1 (en) | Novel transcription activator | |
| JP2025502346A5 (https=) | ||
| KR20240040112A (ko) | 방법 | |
| US11845934B2 (en) | Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA) for enhancing CRISPR mediated genome editing efficiency | |
| EP1618195A2 (en) | Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) | |
| JP6506270B2 (ja) | アンチセンスオリゴヌクレオチド組成物 | |
| CN102229928B (zh) | 人rbbp6基因的小干扰rna及其应用 | |
| CN101590243A (zh) | 微小rna在制备治疗和/或预防淋巴瘤药物中的应用 | |
| JP2022522023A (ja) | カンジダ・アルビカンス感染をコントロールするためのアンチセンスオリゴマー | |
| JP5520931B2 (ja) | Ｍｙｃ下流遺伝子を標的とした配列特異的発現調節剤、及びｍｙｃ下流遺伝子の標的又は標的群を決定する方法 | |
| US20220064238A1 (en) | Methods And Compositions For Modifying Transcription Factor Activity by Targeting The Human Mediator Complex Using Cell Penetrating Memetic Peptides And Methods of Treating Cancer Using The Same |